"While we still lack a complete cause and effect model of Alzheimer’s disease, there is no doubt that the etiology is multifaceted and nonlinear. This accounts for the fact that it takes an incredibly long time for Alzheimer’s disease to develop. I mention this because one of the major problems with FDA approval has always been that it insists on utilizing the same framework and methodology of approving drugs designed to treat long-term diseases as it would with short-term diseases."
Robert Trent is a graduate student who blogs at Medaphysics.
He shares his story and discusses his KevinMD article, "Does the FDA approval of aducanumab mark the return of science-based medicine?" (https://www.kevinmd.com/blog/2021/07/does-the-fda-approval-of-aducanumab-mark-the-return-of-science-based-medicine.html)
Hosted by Kevin Pho, MD, The Podcast by KevinMD shares the stories of the many who intersect with our health care system but are rarely heard from. Welcome to The Podcast by KevinMD.
Subscribe on Apple Podcasts:
https://podcasts.apple.com/us/podcast/the-podcast-by-kevinmd/id1515033137
Subscribe on Google Podcasts:
https://podcasts.google.com/?feed=aHR0cHM6Ly9rZXZpbm1kLmxpYnN5bi5jb20vcnNz
Subscribe on Spotify:
https://open.spotify.com/show/3IbkuWWy0WRrpLkO8xvnAC
